GR3027686T3 - (-)-(s)-2,8-dimethyl-3-methylene-1-oxa-8-azaspiro 4,5]decane l-tartrate - Google Patents

(-)-(s)-2,8-dimethyl-3-methylene-1-oxa-8-azaspiro 4,5]decane l-tartrate

Info

Publication number
GR3027686T3
GR3027686T3 GR980401862T GR980401862T GR3027686T3 GR 3027686 T3 GR3027686 T3 GR 3027686T3 GR 980401862 T GR980401862 T GR 980401862T GR 980401862 T GR980401862 T GR 980401862T GR 3027686 T3 GR3027686 T3 GR 3027686T3
Authority
GR
Greece
Prior art keywords
azaspiro
oxa
decane
tartrate
methylene
Prior art date
Application number
GR980401862T
Other languages
English (en)
Inventor
Shin-Ichi Tsukamoto
Takeru Kohinata
Mitsuo Fujii
Sakiko Tomizawa
Original Assignee
Yamanouchi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharma Co Ltd filed Critical Yamanouchi Pharma Co Ltd
Publication of GR3027686T3 publication Critical patent/GR3027686T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
GR980401862T 1991-05-15 1998-08-20 (-)-(s)-2,8-dimethyl-3-methylene-1-oxa-8-azaspiro 4,5]decane l-tartrate GR3027686T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP13961991 1991-05-15
PCT/JP1992/000548 WO1992020683A1 (en) 1991-05-15 1992-04-27 (-)-(s)-2,8-dimethyl-3-methylene-1-oxa-8-azaspiro[4,5]decane l-tartrate

Publications (1)

Publication Number Publication Date
GR3027686T3 true GR3027686T3 (en) 1998-11-30

Family

ID=15249510

Family Applications (1)

Application Number Title Priority Date Filing Date
GR980401862T GR3027686T3 (en) 1991-05-15 1998-08-20 (-)-(s)-2,8-dimethyl-3-methylene-1-oxa-8-azaspiro 4,5]decane l-tartrate

Country Status (11)

Country Link
US (1) US5403931A (el)
EP (1) EP0590150B1 (el)
AT (1) ATE168114T1 (el)
AU (1) AU1666392A (el)
CA (1) CA2109117A1 (el)
DE (1) DE69226187T2 (el)
DK (1) DK0590150T3 (el)
ES (1) ES2118814T3 (el)
GR (1) GR3027686T3 (el)
RU (1) RU2057132C1 (el)
WO (1) WO1992020683A1 (el)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE187735T1 (de) * 1993-08-19 2000-01-15 Merck & Co Inc Thermodynamisch stabile kristallform von 4''- deoxy-4''-epi-methylamino avermectin bia/bib benzoesauresalz und verfahren zu seiner herstellung
US6521608B1 (en) * 1998-03-27 2003-02-18 Oregon Health & Science University Vitamin D and its analogs in the treatment of tumors and other hyperproliferative disorders
JP2003063964A (ja) * 2001-08-28 2003-03-05 Senju Pharmaceut Co Ltd ドライアイまたはドライアイを伴なう疾病の予防治療剤
US7491725B2 (en) 2004-02-06 2009-02-17 Bristol-Myers Squibb Company Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
WO2007013661A1 (ja) * 2005-07-26 2007-02-01 Senju Pharmaceutical Co., Ltd. 眼科用経皮吸収型製剤
EP2275095A3 (en) * 2005-08-26 2011-08-17 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
EP2258359A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis by muscarinic receptor modulation with sabcomelin
EP2377530A3 (en) 2005-10-21 2012-06-20 Braincells, Inc. Modulation of neurogenesis by PDE inhibition
EP2314289A1 (en) 2005-10-31 2011-04-27 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
CA2651813A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
WO2007134077A2 (en) 2006-05-09 2007-11-22 Braincells, Inc. 5 ht receptor mediated neurogenesis
AU2007292848A1 (en) 2006-09-08 2008-03-13 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
KR20150116466A (ko) * 2009-01-26 2015-10-15 이스라엘 인스티튜트 포 바이올로지컬 리서치 이환형 헤테로사이클릭 스피로 화합물
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2074441T3 (es) * 1987-10-05 1995-09-16 Yamanouchi Pharma Co Ltd Compuestos espiro heterociclicos y su preparacion.
US5075317A (en) * 1989-06-21 1991-12-24 Fisons Corporation Spirofurane derivatives

Also Published As

Publication number Publication date
US5403931A (en) 1995-04-04
RU2057132C1 (ru) 1996-03-27
DK0590150T3 (da) 1999-04-19
DE69226187D1 (de) 1998-08-13
CA2109117A1 (en) 1992-11-16
EP0590150A1 (en) 1994-04-06
AU1666392A (en) 1992-12-30
DE69226187T2 (de) 1998-10-22
ATE168114T1 (de) 1998-07-15
ES2118814T3 (es) 1998-10-01
WO1992020683A1 (en) 1992-11-26
EP0590150A4 (en) 1994-06-29
EP0590150B1 (en) 1998-07-08

Similar Documents

Publication Publication Date Title
GR3027686T3 (en) (-)-(s)-2,8-dimethyl-3-methylene-1-oxa-8-azaspiro 4,5]decane l-tartrate
PT91553A (pt) Processo de preparacao de uma composicao contendo morfina
IL84425A (en) (s) - (+) -ibuprofen-containing pharmaceutical compositions
GR3020717T3 (en) Preparation and use of salts of the pure enantiomers of alpha-lipoic acid
GR3001185T3 (en) Stable solid pharmaceutical composition containing ibuprofen and codeine
IE900709L (en) Pharmaceutical composition which contains a pharmaceutically¹suitable carrier and the compound having the structure¹(7ó,17ó)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-¹3-one
RU93058306A (ru) Моногидрат l-тартрата(-)-(s)-2,8-диметил-3-метилен-1-окса-8-азаспиро-(4,5)-декана
AU5629690A (en) Carboplatin composition
IL109139A0 (en) Diamine salts of clavulanic acid, their preparation and pharmaceutical compositions containing them
GR3033728T3 (en) Tablets containing thioctic acid with a specified size.
USD335084S (en) Bottle
GR3026105T3 (en) Treatment of cardiac dysfunction with 15-keto-prostaglandin compounds
EP0430552A3 (en) Treatment of pulmonary dysfunction with 15-keto-prostaglandin compounds
GR3031294T3 (en) Optically active 1,4-Dihydropyridine derivatives and methods of producing the same
CA2081812A1 (en) Composition and process for the preparation of articles having moulding stability
USD310274S (en) Dental flosser
USD303427S (en) Combined dental syringe and cap
IL98200A0 (en) Pharmaceutical composition containing a derivative of substituted-l-valyl-l-prolinamide
USD310351S (en) Character indicia encoding desk for mail
EP0339386A3 (en) Bipolar transistor structure for use as a photodetector
TW234715B (el)
JPS57175194A (en) 10b-carboxy-aminoboran and physiologically available salts of same, manufacture and use as neutron catching treatment medicine
AU100912S (en) A rung
IT212028Z2 (it) Tavolo con schema per gioco di societa'.